Skip to content

Clinical Features, Medical Costs and Radiographic Resolution of Community-Acquired Pneumonia in Patients with Chronic Obstructive Pulmonary Disease.

Clinical Features, Medical Costs and Radiographic Resolution of Community-Acquired Pneumonia in Patients with Chronic Obstructive Pulmonary Disease. - Clinical Features, Medical Costs and Radiographic Resolution of CAP in Patients with COPD

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000021699
Enrollment
200
Registered
2016-03-31
Start date
2014-04-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic obstructive pulmonary disease (COPD), Community-acquired pneumonia (CAP)

Interventions

None listed

Sponsors

Hitachinaka General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Pneumonia patients diagnosed as CAP Clinically stable patients with moderate to severe COPD,who are 30 years of age or older and have smoking history or current smokers and stop smoking at the time of giving the consent to this study.. They all provide written, informed consent.

Exclusion criteria

Exclusion criteria: Exclusion criteria: (1) Coexistence of other major pulmonary diseases such as asthma, bronchiectasis, pulmonary fibrosis, tuberculosis, and pulmonary cancer diagnosed by imaging modalities and/or laboratory findings. Asthma is excluded based on clinical history and/or laboratory findings, including levels of IgE and/or eosinophils in blood and/or sputum, but not based on reversibility of airflow limitation. (2)patients with cancers (3)patients with other serious complocations (4) Those who are considered as inappropriate subjects for any reasons.

Design outcomes

Primary

MeasureTime frame
The rate of radiographic clearance of CAP

Secondary

MeasureTime frame
Clinical Features of CAP, Medical Cost

Countries

Japan

Contacts

Public ContactShinji Teramoto

Hitachinaka General Hospital Department of pulmonary medicine

shinjit-tky@umin.ac.jp029-354-5111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026